BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 18231949)

  • 1. On the road to gene therapy for beta-thalassemia and sickle cell anemia.
    Bank A
    Pediatr Hematol Oncol; 2008; 25(1):1-4. PubMed ID: 18231949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in globin gene transfer for the treatment of beta-thalassemia and sickle cell anemia.
    Sadelain M
    Curr Opin Hematol; 2006 May; 13(3):142-8. PubMed ID: 16567956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Globin gene transfer as a potential treatment for the beta-thalassaemias and sickle cell disease.
    Sadelain M
    Vox Sang; 2004 Jul; 87 Suppl 2():235-42. PubMed ID: 15209924
    [No Abstract]   [Full Text] [Related]  

  • 4. Gene therapy for hemoglobinopathies: are we there yet?
    Puthenveetil G; Malik P
    Curr Hematol Rep; 2004 Jul; 3(4):298-305. PubMed ID: 15217560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase I/II clinical trial of beta-globin gene therapy for beta-thalassemia.
    Bank A; Dorazio R; Leboulch P
    Ann N Y Acad Sci; 2005; 1054():308-16. PubMed ID: 16339679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards gene therapy of hemoglobinopathies.
    Beuzard Y
    Semin Hematol; 1996 Jan; 33(1):43-52. PubMed ID: 8714584
    [No Abstract]   [Full Text] [Related]  

  • 7. Hemoglobin gene therapy for β-thalassemia.
    Bank A
    Hematol Oncol Clin North Am; 2010 Dec; 24(6):1187-201. PubMed ID: 21075288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Globin gene transfer for treatment of the beta-thalassemias and sickle cell disease.
    Sadelain M; Rivella S; Lisowski L; Samakoglu S; Rivière I
    Best Pract Res Clin Haematol; 2004 Sep; 17(3):517-34. PubMed ID: 15498721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene therapy for the hemoglobin disorders.
    Persons DA; Nienhuis AW
    Curr Hematol Rep; 2003 Jul; 2(4):348-55. PubMed ID: 12901333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress toward safe and effective gene therapy for beta-thalassemia and sickle cell disease.
    Lebensburger J; Persons DA
    Curr Opin Drug Discov Devel; 2008 Mar; 11(2):225-32. PubMed ID: 18283610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Future prospects for treatment of hemoglobinopathies.
    Stamatoyannopoulos JA
    West J Med; 1992 Dec; 157(6):631-6. PubMed ID: 1282285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial correction of murine beta-thalassemia with a gammaretrovirus vector for human gamma-globin.
    Nishino T; Tubb J; Emery DW
    Blood Cells Mol Dis; 2006; 37(1):1-7. PubMed ID: 16814578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current status of globin gene therapy for the treatment of beta-thalassaemia.
    Lisowski L; Sadelain M
    Br J Haematol; 2008 May; 141(3):335-45. PubMed ID: 18410569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel transgenic mouse model produced from lentiviral germline integration for the study of beta-thalassemia gene therapy.
    Li W; Xie S; Guo X; Gong X; Wang S; Lin D; Zhang J; Ren Z; Huang S; Zeng F; Zeng Y
    Haematologica; 2008 Mar; 93(3):356-62. PubMed ID: 18268280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restoration of the balanced alpha/beta-globin gene expression in beta654-thalassemia mice using combined RNAi and antisense RNA approach.
    Xie SY; Ren ZR; Zhang JZ; Guo XB; Wang QX; Wang S; Lin D; Gong XL; Li W; Huang SZ; Zeng F; Zeng YT
    Hum Mol Genet; 2007 Nov; 16(21):2616-25. PubMed ID: 17716993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hematopoietic stem cell mobilization strategies for gene therapy of beta thalassemia and sickle cell disease.
    Yannaki E; Stamatoyannopoulos G
    Ann N Y Acad Sci; 2010 Aug; 1202():59-63. PubMed ID: 20712773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene therapy. Gene gemisch cures sickle cell in mice.
    Marshall E
    Science; 2001 Dec; 294(5550):2268. PubMed ID: 11743172
    [No Abstract]   [Full Text] [Related]  

  • 18. Gene Addition Strategies for β-Thalassemia and Sickle Cell Anemia.
    Dong AC; Rivella S
    Adv Exp Med Biol; 2017; 1013():155-176. PubMed ID: 29127680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapy for globin-chain disorders.
    Blau CA
    N Engl J Med; 1993 Jul; 329(5):364. PubMed ID: 8321277
    [No Abstract]   [Full Text] [Related]  

  • 20. A genetic strategy to treat sickle cell anemia by coregulating globin transgene expression and RNA interference.
    Samakoglu S; Lisowski L; Budak-Alpdogan T; Usachenko Y; Acuto S; Di Marzo R; Maggio A; Zhu P; Tisdale JF; Rivière I; Sadelain M
    Nat Biotechnol; 2006 Jan; 24(1):89-94. PubMed ID: 16378095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.